TransCode Therapeutics In...

NASDAQ: RNAZ · Real-Time Price · USD
10.97
-0.08 (-0.72%)
At close: Aug 15, 2025, 3:59 PM
10.73
-2.19%
After-hours: Aug 15, 2025, 05:33 PM EDT

TransCode Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-16.75M -18.55M -17.56M -6.84M
Depreciation & Amortization
534.86K 516.75K 98.61K 42.47K
Stock-Based Compensation
1.7M 1.04M 395.33K 186K
Other Working Capital
-351K -146.27K -535.2K -1.85M
Other Non-Cash Items
1.54M 1.04M -890.95K 39.47K
Deferred Income Tax
n/a n/a 890.95K 876.19K
Change in Working Capital
-351.48K -1.08M 1.31M 432.39K
Operating Cash Flow
-13.34M -18.07M -15.76M -5.27M
Capital Expenditures
-21.76K -35.61K -100.92K -254.82K
Cash Acquisitions
n/a n/a n/a 3K
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a -100.92M 3.00
Investing Cash Flow
-21.76K -35.61K -100.92K -251.82K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 5.99K -818.55K
Financial Cash Flow
16.4M 15.91M 5.99K 25.52M
Net Cash Flow
3.04M -2.2M -15.86M 20M
Free Cash Flow
-13.36M -18.11M -15.86M -5.52M